Category Archives: Pr Newswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

Majority of patients in this age group with eosinophilic esophagitis (EoE) receiving Dupixent achieved histologic remission, with improvements sustained up to one year Dupixent is the first and only treatment indicated for EoE in the U.S. for this age group TARRYTOWN, N.Y. and PARIS, June 26, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) […]

Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 27, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announces that it has resubmitted the Biologics License Application (BLA) of batoclimab (HBM9161) to the National Medical […]

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

With the focus on improving patient experience and reducing burden on sites  PHILADELPHIA, June 27, 2024 /PRNewswire/ — Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, announced the early adopter launch of its ePatient product. This innovative solution […]

DeepL goes global, bringing innovative Language AI solution to 165 new markets

Language AI pioneer DeepL now offers its industry-leading AI translation solution, DeepL Pro, worldwide DeepL Pro enables businesses to accelerate global expansion, while also unlocking substantial cost and efficiency gains COLOGNE, Germany, June 27, 2024 /PRNewswire/ — DeepL, a global leader in Language AI, today announced the launch of its translation solution for businesses, DeepL Pro, […]

Nutiani report reveals age-agnostic interest and proactive consumers in healthy ageing space

AUCKLAND, New Zealand, June 27, 2024 /PRNewswire/ — Nutiani’s latest Consumer Health and Nutrition Index, conducted in collaboration with Ipsos, indicates a strong and growing consumer focus on ageing healthily. This is underpinned by a strong preventive mindset (88%) and a firm awareness on the role of nutrition in health management (82%) going into one’s […]

Slovenia Celebrates 10 Michelin-Starred Restaurants: Hiša Franko Maintains Three Stars. Restaurant Milka Retains Two, and Pavus Earns a New Star

LJUBLJANA, Slovenia, June 27, 2024 /PRNewswire/ — Slovenian gastronomy has achieved another milestone. In 2024 Michelin Guide for Slovenia, the number of listed restaurants has risen to 63, an increase of four from the previous year. This places Slovenia among Europe’s gastronomic superpowers. Five new restaurants have been awarded the Bib Gourmand for their excellent […]

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), announces the filing of the new composition of matter patent with the U.S. Patent […]

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Results from primary analysis of the SYMON-I pilot clinical study consistent with IL-6 as a predictor of patients who have a mortality event with 28 days after sepsis and septic shock diagnosis and are admitted to the intensive care unit (ICU). ACTON, Mass., June 26, 2024 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today […]

iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD’s Breast Health Suite of AI Solutions NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research demonstrating the efficacy of its ProFound AI […]

BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department […]